2018 Q1 Form 10-K Financial Statement

#000093454918000007 Filed on March 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017
Revenue $62.09M $3.458M $65.40M
YoY Change 601.3% -84.26% -57.17%
Cost Of Revenue $21.74M $10.00K $5.000M
YoY Change 3144.78% -99.7% -77.97%
Gross Profit $40.35M $3.450M $60.50M
YoY Change 392.67% -81.51% -53.46%
Gross Profit Margin 64.98% 99.77% 92.5%
Selling, General & Admin $19.14M $310.0K $42.70M
YoY Change 153.85% -97.67% -28.11%
% of Gross Profit 47.43% 8.99% 70.58%
Research & Development $170.0K $200.0K $1.200M
YoY Change -46.88% -64.29% -61.29%
% of Gross Profit 0.42% 5.8% 1.98%
Depreciation & Amortization $5.344M $5.400M $22.24M
YoY Change -3.54% -14.29% -35.26%
% of Gross Profit 13.24% 156.52% 36.77%
Operating Expenses $24.63M $7.150M $67.20M
YoY Change 84.22% -64.37% -30.86%
Operating Profit $8.970M -$7.330M -$27.27M
YoY Change -177.49% -19.05% -27.1%
Interest Expense -$40.89M -$102.5M $43.60M
YoY Change
% of Operating Profit -455.85%
Other Income/Expense, Net -$40.89M -$103.0M $1.000M
YoY Change -5975.0% -17490.2% 25.31%
Pretax Income -$31.92M -$110.3M $24.64M
YoY Change 193.38% 1203.08% -167.3%
Income Tax $191.0K $20.00K $2.955M
% Of Pretax Income 11.99%
Net Earnings -$32.04M -$110.2M $22.18M
YoY Change 170.82% 938.57% -141.02%
Net Earnings / Revenue -51.6% -3186.9% 33.91%
Basic Earnings Per Share -$0.63
Diluted Earnings Per Share -$632.8K -$2.178M $437.9K
COMMON SHARES
Basic Shares Outstanding 50.64M shares 50.60M shares 50.50M shares
Diluted Shares Outstanding 50.63M shares 50.59M shares 50.69M shares

Balance Sheet

Concept 2018 Q1 2017 Q4 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $179.6M $136.6M $136.6M
YoY Change 23.69% -7.07% -7.07%
Cash & Equivalents $150.3M $136.6M $136.6M
Short-Term Investments $29.40M $0.00 $0.00
Other Short-Term Assets $3.800M $2.900M $2.900M
YoY Change -77.11% -80.27% -80.27%
Inventory
Prepaid Expenses
Receivables $4.695M $153.0K $200.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $188.2M $139.7M $139.7M
YoY Change 10.92% -25.89% -25.89%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.195M $2.195M $106.9M
YoY Change 272.5% 5245.0%
Other Assets $1.193M $207.0K $200.0K
YoY Change 255.06% -66.5% -60.0%
Total Long-Term Assets $129.6M $169.1M $169.1M
YoY Change 25.64% 57.26% 57.3%
TOTAL ASSETS
Total Short-Term Assets $188.2M $139.7M $139.7M
Total Long-Term Assets $129.6M $169.1M $169.1M
Total Assets $317.8M $308.8M $308.8M
YoY Change 16.48% 4.31% 4.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.000M $8.000M
YoY Change -23.08% -44.06%
Accrued Expenses $7.900M
YoY Change -28.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $48.98M $9.557M $9.600M
YoY Change 231.15% -66.1% -65.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.805M $3.552M $3.600M
YoY Change 375.0% 862.6% 800.0%
Total Long-Term Liabilities $1.805M $3.552M $3.600M
YoY Change 375.0% 862.6% 800.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.98M $9.557M $9.600M
Total Long-Term Liabilities $1.805M $3.552M $3.600M
Total Liabilities $50.78M $13.11M $14.50M
YoY Change 234.75% -54.1% -52.3%
SHAREHOLDERS EQUITY
Retained Earnings -$317.5M -$320.0M
YoY Change -10.31% -6.48%
Common Stock $51.00K $51.00K
YoY Change 0.0% 2.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $34.64M $34.64M
YoY Change 0.0% 0.0%
Treasury Stock Shares 1.729M shares 1.729M shares
Shareholders Equity $265.5M $294.3M $294.3M
YoY Change
Total Liabilities & Shareholders Equity $317.8M $308.8M $308.8M
YoY Change 16.48% 4.31% 4.32%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017
OPERATING ACTIVITIES
Net Income -$32.04M -$110.2M $22.18M
YoY Change 170.82% 938.57% -141.02%
Depreciation, Depletion And Amortization $5.344M $5.400M $22.24M
YoY Change -3.54% -14.29% -35.26%
Cash From Operating Activities $49.97M -$21.90M $12.97M
YoY Change -5219.88% -300.92% -61.93%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $2.000K
YoY Change -100.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities -$36.30M $57.40M -$16.10M
YoY Change -49.93% 6277.78% -59.14%
Cash From Investing Activities -$36.31M $57.40M -$16.11M
YoY Change -49.9% 8100.0% -60.34%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net $7.000K $0.00
YoY Change -72.0% -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $24.00K 100.0K $700.0K
YoY Change -89.57% -162.84%
NET CHANGE
Cash From Operating Activities $49.97M -21.90M $12.97M
Cash From Investing Activities -$36.31M 57.40M -$16.11M
Cash From Financing Activities $24.00K 100.0K $700.0K
Net Change In Cash $13.69M 35.60M -$2.448M
YoY Change -118.69% 206.9% -68.14%
FREE CASH FLOW
Cash From Operating Activities $49.97M -$21.90M $12.97M
Capital Expenditures $0.00 $0.00 $2.000K
Free Cash Flow $49.97M -$21.90M $12.96M
YoY Change -5219.88% -297.3% -61.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 actg A10 Warrant
A10Warrant
809400 shares
CY2016Q4 actg Accrued Expenses And Contributions Ip Fund
AccruedExpensesAndContributionsIpFund
2394000 USD
CY2017Q4 actg Accrued Expenses And Contributions Ip Fund
AccruedExpensesAndContributionsIpFund
2567000 USD
CY2016Q4 actg Accrued Legal Expenses Patent
AccruedLegalExpensesPatent
6564000 USD
CY2017Q4 actg Accrued Legal Expenses Patent
AccruedLegalExpensesPatent
5479000 USD
CY2017Q4 actg Beneficial Ownership Percentage Limit
BeneficialOwnershipPercentageLimit
0.049
CY2018Q1 actg Bitzumi Warrantto Purchase Common Shares
BitzumiWarranttoPurchaseCommonShares
4000000 USD
CY2018Q1 actg Bitzumitotal Investment
BitzumitotalInvestment
10000000 USD
CY2017Q1 actg Bridge Installment Shares
BridgeInstallmentShares
90000 shares
CY2017Q1 actg Bridge Warrant Share
BridgeWarrantShare
157000 shares
CY2017Q1 actg Bridgeloanstatedinterestrate
Bridgeloanstatedinterestrate
0.08
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7994000 USD
CY2016Q4 actg Cash And Other Assets Ip Fund
CashAndOtherAssetsIpFund
1118000 USD
CY2016 actg Changeinfairvalueofinvestment
Changeinfairvalueofinvestment
0 USD
CY2017 actg Changeinfairvalueofinvestment
Changeinfairvalueofinvestment
42239000 USD
CY2015 actg Commonstockdividendsdeclaredquarterly
Commonstockdividendsdeclaredquarterly
0.125
CY2015 actg Contingent Legal Fees
ContingentLegalFees
16169000 USD
CY2016Q1 actg Contingent Legal Fees
ContingentLegalFees
4109000 USD
CY2017Q4 actg Cash And Other Assets Ip Fund
CashAndOtherAssetsIpFund
986000 USD
CY2015 actg Cash Paid For State Income Taxes
CashPaidForStateIncomeTaxes
211000 USD
CY2016 actg Cash Paid For State Income Taxes
CashPaidForStateIncomeTaxes
223000 USD
CY2017 actg Cash Paid For State Income Taxes
CashPaidForStateIncomeTaxes
181000 USD
CY2017 actg Cash Paidfor Investment
CashPaidforInvestment
2250000 USD
CY2017Q2 actg Cashpaidforprimarywarrantexercise
Cashpaidforprimarywarrantexercise
29300000 USD
CY2015 actg Changeinfairvalueofinvestment
Changeinfairvalueofinvestment
0 USD
CY2016Q2 actg Contingent Legal Fees
ContingentLegalFees
10418000 USD
CY2016Q3 actg Contingent Legal Fees
ContingentLegalFees
7709000 USD
CY2016Q4 actg Contingent Legal Fees
ContingentLegalFees
4238000 USD
CY2016 actg Contingent Legal Fees
ContingentLegalFees
26474000 USD
CY2017Q1 actg Contingent Legal Fees
ContingentLegalFees
627000 USD
CY2017Q2 actg Contingent Legal Fees
ContingentLegalFees
3236000 USD
CY2017Q3 actg Contingent Legal Fees
ContingentLegalFees
12173000 USD
CY2017Q4 actg Contingent Legal Fees
ContingentLegalFees
646000 USD
CY2017 actg Contingent Legal Fees
ContingentLegalFees
16682000 USD
CY2016Q4 actg Deferred Tax Asset Operating And Capital Loss Carryforwards And Credits
DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits
83323000 USD
CY2017Q4 actg Deferred Tax Asset Operating And Capital Loss Carryforwards And Credits
DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits
90871000 USD
CY2017 actg Deferred Tax Asset Revaluation
DeferredTaxAssetRevaluation
25261000 USD
CY2016Q4 actg Deferred Tax Liabilities Fixed Assets And Intangibles
DeferredTaxLiabilitiesFixedAssetsAndIntangibles
0 USD
CY2017Q4 actg Deferred Tax Liabilities Fixed Assets And Intangibles
DeferredTaxLiabilitiesFixedAssetsAndIntangibles
10587000 USD
CY2016Q4 actg Deferred Tax Liabilities Net Of Deferred Tax Assets
DeferredTaxLiabilitiesNetOfDeferredTaxAssets
0 USD
CY2017Q4 actg Deferred Tax Liabilities Net Of Deferred Tax Assets
DeferredTaxLiabilitiesNetOfDeferredTaxAssets
0 USD
CY2016Q4 actg Deferredtaxassetsintangiblesandfixedassets
Deferredtaxassetsintangiblesandfixedassets
14343000 USD
CY2017Q4 actg Deferredtaxassetsintangiblesandfixedassets
Deferredtaxassetsintangiblesandfixedassets
6197000 USD
CY2015 actg Dividendsattributabletocommonstockholdersunderthetwoclassmethod
Dividendsattributabletocommonstockholdersunderthetwoclassmethod
24740000 USD
CY2016 actg Dividendsattributabletocommonstockholdersunderthetwoclassmethod
Dividendsattributabletocommonstockholdersunderthetwoclassmethod
0 USD
CY2017 actg Dividendsattributabletocommonstockholdersunderthetwoclassmethod
Dividendsattributabletocommonstockholdersunderthetwoclassmethod
0 USD
CY2015 actg Effective Income Tax Rate Reconcilation Expired Net Operating Losses
EffectiveIncomeTaxRateReconcilationExpiredNetOperatingLosses
0.01
CY2016 actg Effective Income Tax Rate Reconcilation Expired Net Operating Losses
EffectiveIncomeTaxRateReconcilationExpiredNetOperatingLosses
0.00
CY2017 actg Effective Income Tax Rate Reconcilation Expired Net Operating Losses
EffectiveIncomeTaxRateReconcilationExpiredNetOperatingLosses
0.00
CY2015 actg Effectiveincometaxratereconciliationgoodwill
Effectiveincometaxratereconciliationgoodwill
0.07
CY2016 actg Effectiveincometaxratereconciliationgoodwill
Effectiveincometaxratereconciliationgoodwill
0.00
CY2017 actg Effectiveincometaxratereconciliationgoodwill
Effectiveincometaxratereconciliationgoodwill
0.00
CY2015 actg Effectivetaxrateexcludingvaluationallowance
Effectivetaxrateexcludingvaluationallowance
-0.28
CY2016 actg Effectivetaxrateexcludingvaluationallowance
Effectivetaxrateexcludingvaluationallowance
-0.33
CY2017 actg Effectivetaxrateexcludingvaluationallowance
Effectivetaxrateexcludingvaluationallowance
0.47
CY2017Q4 actg Employee Service Sharebased Compensation Awardswith Market Conditions Compensation Cost Notyet Recognized
EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognized
0 USD
CY2017Q4 actg Employee Service Sharebased Compensation Awardswith Performance Condiditons Compensation Cost Notyet Recognized
EmployeeServiceSharebasedCompensationAwardswithPerformanceCondiditonsCompensationCostNotyetRecognized
0 USD
CY2015Q4 actg Estimated Carrying Valueof Reporting Unit Market Capitalization Plus Cost Synergies Approach
EstimatedCarryingValueofReportingUnitMarketCapitalizationPlusCostSynergiesApproach
344300000 USD
CY2015Q4 actg Estimated Fair Valueofthe Reporting Unit
EstimatedFairValueoftheReportingUnit
252000000 USD
CY2017Q4 actg Fair Valueof Profits Interest
FairValueofProfitsInterest
3041000 USD
CY2017Q1 actg Fair Valueof Profits Interest
FairValueofProfitsInterest
722000 USD
CY2017Q4 actg Federal Deferred Tax Asset Impactof Asu201609
FederalDeferredTaxAssetImpactofASU201609
21350000 USD
CY2017Q4 actg Federal Nol Annual Utilization Limit
FederalNolAnnualUtilizationLimit
14100000 USD
CY2016Q3 actg First Loan Warrant
FirstLoanWarrant
700000 USD
CY2017Q4 actg Foreign Tax Credits Additional Paid In Capital Benefit
ForeignTaxCreditsAdditionalPaidInCapitalBenefit
51126000 USD
CY2015 actg Foreign Withholding Taxes
ForeignWithholdingTaxes
4421000 USD
CY2016 actg Foreign Withholding Taxes
ForeignWithholdingTaxes
14776000 USD
CY2017 actg Foreign Withholding Taxes
ForeignWithholdingTaxes
2865000 USD
CY2016Q4 actg Foreigntaxespayable
Foreigntaxespayable
3150000 USD
CY2017Q4 actg Foreigntaxespayable
Foreigntaxespayable
15000 USD
CY2015 actg Gainon Conversionof Loanand Accrued Interest
GainonConversionofLoanandAccruedInterest
0 USD
CY2016 actg Gainon Conversionof Loanand Accrued Interest
GainonConversionofLoanandAccruedInterest
0 USD
CY2017 actg Gainon Conversionof Loanand Accrued Interest
GainonConversionofLoanandAccruedInterest
2671000 USD
CY2015 actg Gainonexerciseof Primary Warrant
GainonexerciseofPrimaryWarrant
0 USD
CY2016 actg Gainonexerciseof Primary Warrant
GainonexerciseofPrimaryWarrant
0 USD
CY2017 actg Gainonexerciseof Primary Warrant
GainonexerciseofPrimaryWarrant
4616000 USD
CY2016 actg Ip Fund Gainfrom Operations
IPFundGainfromOperations
556000 USD
CY2017 actg Ip Fund Gainfrom Operations
IPFundGainfromOperations
390000 USD
CY2016 actg Ip Fund Net Loss
IPFundNetLoss
-1569000 USD
CY2017 actg Ip Fund Net Loss
IPFundNetLoss
-1333000 USD
CY2016 actg Ip Fund Net Lossin Equity Method Investment
IPFundNetLossinEquityMethodInvestment
-1013000 USD
CY2017 actg Ip Fund Net Lossin Equity Method Investment
IPFundNetLossinEquityMethodInvestment
-943000 USD
CY2016 actg Ip Fund Operatingexpenses
IPFundOperatingexpenses
-572000 USD
CY2017 actg Ip Fund Operatingexpenses
IPFundOperatingexpenses
-390000 USD
CY2015 actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
527000 USD
CY2016 actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
-970000 USD
CY2017 actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
-12307000 USD
CY2017 actg Investmentat Fair Value Purchasesand Issues
InvestmentatFairValuePurchasesandIssues
55228000 USD
CY2018Q1 actg Investmentin Bitzumi
InvestmentinBitzumi
1000000 USD
CY2018Q1 actg Investmentin Bitzumi Remaining Amount
InvestmentinBitzumiRemainingAmount
9000000 USD
CY2018Q1 actg Investmentin Miso Robotics
InvestmentinMisoRobotics
6000000 USD
CY2016Q4 actg Investments Ip Fund
InvestmentsIpFund
2933000 USD
CY2017Q4 actg Investments Ip Fund
InvestmentsIpFund
1905000 USD
CY2016Q4 actg Investmentsatfairvalue
Investmentsatfairvalue
0 USD
CY2017Q4 actg Investmentsatfairvalue
Investmentsatfairvalue
104754000 USD
CY2016Q4 actg Investmentwarrants
Investmentwarrants
1960000 USD
CY2017Q4 actg Investmentwarrants
Investmentwarrants
0 USD
CY2017 actg Lag Time In Recognizing Revenues From Licensees Quarter
LagTimeInRecognizingRevenuesFromLicenseesQuarter
P3M
CY2015 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
39373000 USD
CY2016Q1 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
7723000 USD
CY2016Q2 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
7324000 USD
CY2016Q3 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
7348000 USD
CY2016Q4 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
5463000 USD
CY2016 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
27858000 USD
CY2017Q1 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
6386000 USD
CY2017Q2 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
4134000 USD
CY2017Q3 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
4073000 USD
CY2017Q4 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
3626000 USD
CY2017 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
18219000 USD
CY2017 actg Lossonfairvalueinvestmentnet
Lossonfairvalueinvestmentnet
49526000 USD
CY2016Q3 actg Maximum Investmentin Veritone
MaximumInvestmentinVeritone
50000000 USD
CY2016Q4 actg Net Assets Fund Related
NetAssetsFundRelated
1657000 USD
CY2017Q4 actg Net Assets Fund Related
NetAssetsFundRelated
324000 USD
CY2014 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
6 patents
CY2015 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
3 patents
CY2016 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
2 patents
CY2017 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
1 patents
CY2017Q4 actg Operating Loss Carryforwards Federal
OperatingLossCarryforwardsFederal
180621000 USD
CY2017Q4 actg Operating Loss Carryforwards State
OperatingLossCarryforwardsState
17850000 USD
CY2017 actg Ownership Percent Of Voting Stock
OwnershipPercentOfVotingStock
0.10
CY2015 actg Patent Acquisition Costs Included In Accrued Expenses
PatentAcquisitionCostsIncludedInAccruedExpenses
1000000 USD
CY2016 actg Patent Acquisition Costs Included In Accrued Expenses
PatentAcquisitionCostsIncludedInAccruedExpenses
0 USD
CY2017 actg Patent Acquisition Costs Included In Accrued Expenses
PatentAcquisitionCostsIncludedInAccruedExpenses
0 USD
CY2016Q4 actg Patents Net Of Accumulated Amortization
PatentsNetOfAccumulatedAmortization
86319000 USD
CY2017Q4 actg Patents Net Of Accumulated Amortization
PatentsNetOfAccumulatedAmortization
61917000 USD
CY2018Q1 actg Percentageofownership Miso Robotics
PercentageofownershipMisoRobotics
0.30
CY2017Q4 actg Percentageofownership Veritone
PercentageofownershipVeritone
0.23
CY2017Q2 actg Percentageofownership Veritone
PercentageofownershipVeritone
0.20
CY2015 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
3391000 USD
CY2016Q1 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
522000 USD
CY2016Q2 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
1334000 USD
CY2016Q3 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
666000 USD
CY2016Q4 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
557000 USD
CY2016 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
3079000 USD
CY2017Q1 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
320000 USD
CY2017Q2 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
433000 USD
CY2017Q3 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
241000 USD
CY2017Q4 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
195000 USD
CY2017 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
1189000 USD
CY2016 actg Revenues Ip Fund
RevenuesIPFund
-16000 USD
CY2017 actg Revenues Ip Fund
RevenuesIPFund
0 USD
CY2016Q4 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
13908000 USD
CY2017Q4 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
1601000 USD
CY2016Q3 actg Secured Convertible Promissory Note
SecuredConvertiblePromissoryNote
20000000 USD
CY2016Q3 actg Secured Promissory Note Advance
SecuredPromissoryNoteAdvance
10000000 USD
CY2017Q4 actg Sharebased Awards Restricted Stock Units Vested Oustanding
SharebasedAwardsRestrictedStockUnitsVestedOustanding
60000 shares
CY2016Q4 actg Sharebased Compensation Arrangement Restricted Stock Units Nonvested
SharebasedCompensationArrangementRestrictedStockUnitsNonvested
14000 shares
CY2017Q4 actg Sharebased Compensation Arrangement Restricted Stock Units Nonvested
SharebasedCompensationArrangementRestrictedStockUnitsNonvested
2000 shares
CY2016 actg Sharebased Compensation Arrangementby Sharebased Payment Award All Grants Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardAllGrantsFairValue
12152000 USD
CY2017 actg Sharebased Compensation Arrangementby Sharebased Payment Award All Grants Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardAllGrantsFairValue
2930000 USD
CY2017 actg Sharebased Compensation Arrangementby Sharebased Payment Award Options Vested Duringthe Period Aggregate Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedDuringthePeriodAggregateIntrinsicValue
351000 USD
CY2016 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Grantsin Period Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsGrantsinPeriodWeightedAverageGrantDateFairValue
16.72
CY2017 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Grantsin Period Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsGrantsinPeriodWeightedAverageGrantDateFairValue
0.00
CY2016Q4 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsNonvestedWeightedAverageGrantDateFairValue
16.27
CY2017Q4 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsNonvestedWeightedAverageGrantDateFairValue
16.72
CY2017 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Vested During Period
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedDuringPeriod
-12000 shares
CY2015 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Vestedin Period Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodFairValue
480000 USD
CY2016 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Vestedin Period Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodFairValue
324000 USD
CY2017 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Vestedin Period Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodFairValue
200000 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4421000 USD
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
17926000 USD
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2865000 USD
CY2017 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Vestedin Period Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodWeightedAverageGrantDateFairValue
16.18
CY2017Q4 actg Sharebased Compensation Arrangementby Sharebased Payment Award Restricted Stock Units Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsWeightedAverageGrantDateFairValue
15.38
CY2016 actg Sharebased Compensation Arrangementby Sharebased Payment Award Total Grants Duringthe Period
SharebasedCompensationArrangementbySharebasedPaymentAwardTotalGrantsDuringthePeriod
6022000000 shares
CY2017 actg Sharebased Compensation Arrangementby Sharebased Payment Award Total Grants Duringthe Period
SharebasedCompensationArrangementbySharebasedPaymentAwardTotalGrantsDuringthePeriod
1368000000 shares
CY2017 actg Sharebased Compensation Arrangmentby Sharebased Payment Award Options Granted Fair Value
SharebasedCompensationArrangmentbySharebasedPaymentAwardOptionsGrantedFairValue
2930000 USD
CY2017Q4 actg State Deferred Tax Asset Impactof Asu201609
StateDeferredTaxAssetImpactofASU201609
1559000 USD
CY2016Q4 actg Total Assets Ip Fund
TotalAssetsIpFund
4051000 USD
CY2017Q4 actg Total Assets Ip Fund
TotalAssetsIpFund
2891000 USD
CY2017Q2 actg Unamortizedloandiscount
Unamortizedloandiscount
1700000 USD
CY2017Q4 actg Unvested Shareswith Market Based Vesting Conditions
UnvestedShareswithMarketBasedVestingConditions
1687500 shares
CY2017Q1 actg Upfront Shares
UpfrontShares
60000 shares
CY2017Q1 actg Veritone Bridge Loan Advance1
VeritoneBridgeLoanAdvance1
1000000 USD
CY2017Q1 actg Veritone Bridge Loan Advance3and4
VeritoneBridgeLoanAdvance3and4
2000000 USD
CY2016Q3 actg Veritone Primary Warrant
VeritonePrimaryWarrant
50000000 USD
CY2018Q1 actg Warranttopurchasecommonshare Bitzumi
WarranttopurchasecommonshareBitzumi
30000000 shares
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0000934549
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50637882 shares
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q2 dei Entity Public Float
EntityPublicFloat
202307000 USD
CY2017 dei Entity Registrant Name
EntityRegistrantName
ACACIA RESEARCH CORP
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 invest Investment Maturity Date1
InvestmentMaturityDate1
2017-12-31
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14283000 USD
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7956000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26750000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
153000 USD
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
630000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1967000 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1364000 USD
CY2016Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
533000 USD
CY2017Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
294000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-76000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-88000 USD
CY2017 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
642453000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
648996000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
53067000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10760000 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10759000 USD
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6467000 USD
CY2016Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6222000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34208000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5515000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5571000 USD
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5625000 USD
CY2017Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5443000 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22154000 USD
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71468 shares
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3682532 shares
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4425187 shares
CY2016Q4 us-gaap Assets
Assets
296003000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4800000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18188000 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2955000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
379000 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
262000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2017Q4 us-gaap Assets
Assets
308768000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
188490000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
139695000 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
19443000 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
19403000 USD
CY2015 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
617000 USD
CY2016 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
40000 USD
CY2016 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2017Q1 us-gaap Bridge Loan
BridgeLoan
4000000 USD
CY2017Q2 us-gaap Bridge Loan
BridgeLoan
4000000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134466000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
135223000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127540000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
136604000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
757000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7683000 USD
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9064000 USD
CY2018Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7279000 shares
CY2015 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.500
CY2016 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.000
CY2017 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.000
CY2015 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50476042 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50639926 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50476042 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50639926 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
50000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
51000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-159898000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53928000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22168000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-157340000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-54660000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
21672000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
3000000 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
90000 USD
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
13.6088
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
102789000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
162000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10611000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.14
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
100889000 USD
CY2016Q4 us-gaap Deferred Tax Assets Investment In Subsidiaries
DeferredTaxAssetsInvestmentInSubsidiaries
2195000 USD
CY2017Q4 us-gaap Deferred Tax Assets Investment In Subsidiaries
DeferredTaxAssetsInvestmentInSubsidiaries
984000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
162000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10611000 USD
CY2016Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
90000 USD
CY2017Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
35000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2416000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2635000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
422000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
167000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
102627000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
90278000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
162000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
24000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
10587000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53289000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34355000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22243000 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.25
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.81
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
3.13
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.18
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.44
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.03
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.08
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.50
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.12
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.35
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.35
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.31
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.83
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.37
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.00
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.00
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-1.02
CY2015 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.01
CY2016 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.01
CY2017 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.01
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.00
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.00
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.03
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.03
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.50
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.08
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
-0.03
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
-0.49
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.00
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1593000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
465000 USD
CY2017Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.23
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2195000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0 USD
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
104754000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
6197000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
20542000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5256000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5261000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6134000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
18527000 USD
CY2015 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-123000 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38176000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
30100000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7535000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8334000 USD
CY2016Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9056000 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32919000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6916000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6734000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12715000 USD
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
-335000 USD
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26030000 USD
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
30149000 USD
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
74731000 USD
CY2016Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2016Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
40165000 USD
CY2016Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2016Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2175000 USD
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
42340000 USD
CY2017Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2017Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2017Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2248000 USD
CY2017Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2248000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-152678000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9705000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34994000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16551000 USD
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8463000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36611000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10880000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12786000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
158585000 USD
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-110280000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24639000 USD
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-220000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4800000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5927000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9655000 USD
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2414000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18188000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1241000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1478000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
216000 USD
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2955000 USD
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0.21 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2570000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3006000 USD
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6349000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13332000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6750000 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26597000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-619000 USD
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1593000 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-135000 USD
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-10725000 USD
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-787000 USD
CY2017 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
11512000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
-56000 USD
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
798000 USD
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
1605000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1926000 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1795000 USD
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1392000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
28560000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
13109000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
296003000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
308768000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28191000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9557000 USD
CY2015 us-gaap Licenses Revenue
LicensesRevenue
125037000 USD
CY2016 us-gaap Licenses Revenue
LicensesRevenue
152699000 USD
CY2017 us-gaap Licenses Revenue
LicensesRevenue
65402000 USD
CY2016Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
18616000 USD
CY2017Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
0 USD
CY2017Q2 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
20700000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
1854000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
1358000 USD
CY2015 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
-4105000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28601000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1114000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
700000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
39307000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40630000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16114000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9949000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34061000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24478000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-160036000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-9965000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-40573000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
7082000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-10611000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-54067000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-11830000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-14252000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
158465000 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-110203000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
22180000 USD
CY2015 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2558000 USD
CY2016Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
68000 USD
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-348000 USD
CY2016Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-186000 USD
CY2016Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-266000 USD
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-732000 USD
CY2017Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-291000 USD
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12000 USD
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-96000 USD
CY2017Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-97000 USD
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-496000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-160730000 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-54067000 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22147000 USD
CY2015 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
277659000 USD
CY2016Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
34423000 USD
CY2016Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
76293000 USD
CY2016Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
48368000 USD
CY2016Q4 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
31024000 USD
CY2016 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
190108000 USD
CY2017Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
20430000 USD
CY2017Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
24381000 USD
CY2017Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
37075000 USD
CY2017Q4 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10788000 USD
CY2017 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
92674000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-152622000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9702000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34942000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16290000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-9055000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-37409000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11576000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7924000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-442000 USD
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7330000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-27272000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2598000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1213000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
16000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1369000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
476000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
339000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
618000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
207000 USD
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-123000 USD
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
77000 USD
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
58000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-617000 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-22000 USD
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
30000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-356000 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
40000 USD
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-40000 USD
CY2015 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4141000 USD
CY2016Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1742000 USD
CY2016Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
-1242000 USD
CY2016Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2016Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2016 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
500000 USD
CY2017Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2017Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2017Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2017Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1200000 USD
CY2017 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1200000 USD
CY2015 us-gaap Other Income
OtherIncome
0 USD
CY2016 us-gaap Other Income
OtherIncome
0 USD
CY2017 us-gaap Other Income
OtherIncome
1000000 USD
CY2016Q4 us-gaap Other Liabilities
OtherLiabilities
369000 USD
CY2017Q4 us-gaap Other Liabilities
OtherLiabilities
3552000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-56000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
261000 USD
CY2016Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
592000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
798000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
696000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4862000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
159027000 USD
CY2017Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-102950000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51911000 USD
CY2015 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-109000 USD
CY2016 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-477000 USD
CY2017 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-374000 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
82000 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
45000 USD
CY2015 us-gaap Payments Of Dividends
PaymentsOfDividends
25434000 USD
CY2016 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
23296000 USD
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
62633000 USD
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
448388000 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19504000 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1225000 USD
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2015 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
CY2016 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
20000000 USD
CY2017 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
4000000 USD
CY2015 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 USD
CY2016 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 USD
CY2017 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
31514000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 USD
CY2015 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
4105000 USD
CY2016 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1358000 USD
CY2017 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3245000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2938000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
82115000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
43232000 USD
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
82115000 USD
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
43232000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
938000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
326000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
745000 USD
CY2015 us-gaap Profit Loss
ProfitLoss
-157478000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-9897000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-40921000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
6896000 USD
CY2016Q4 us-gaap Profit Loss
ProfitLoss
-10877000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
-54799000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-12121000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-14264000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
158369000 USD
CY2017Q4 us-gaap Profit Loss
ProfitLoss
-110300000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
21684000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11512000 USD
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
11512000 USD
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-342198000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-320018000 USD
CY2016Q1 us-gaap Revenues
Revenues
24721000 USD
CY2016Q2 us-gaap Revenues
Revenues
41351000 USD
CY2016Q3 us-gaap Revenues
Revenues
64658000 USD
CY2016Q4 us-gaap Revenues
Revenues
21969000 USD
CY2017Q1 us-gaap Revenues
Revenues
8854000 USD
CY2017Q2 us-gaap Revenues
Revenues
16457000 USD
CY2017Q3 us-gaap Revenues
Revenues
36633000 USD
CY2017Q4 us-gaap Revenues
Revenues
3458000 USD
CY2015 us-gaap Royalty Expense
RoyaltyExpense
18462000 USD
CY2016Q1 us-gaap Royalty Expense
RoyaltyExpense
1573000 USD
CY2016Q2 us-gaap Royalty Expense
RoyaltyExpense
0 USD
CY2016Q3 us-gaap Royalty Expense
RoyaltyExpense
17844000 USD
CY2016Q4 us-gaap Royalty Expense
RoyaltyExpense
3313000 USD
CY2016 us-gaap Royalty Expense
RoyaltyExpense
22730000 USD
CY2017Q1 us-gaap Royalty Expense
RoyaltyExpense
666000 USD
CY2017Q2 us-gaap Royalty Expense
RoyaltyExpense
4273000 USD
CY2017Q3 us-gaap Royalty Expense
RoyaltyExpense
0 USD
CY2017Q4 us-gaap Royalty Expense
RoyaltyExpense
13000 USD
CY2017 us-gaap Royalty Expense
RoyaltyExpense
4952000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
11048000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
9062000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
8885000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
90000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
9.10
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
333000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
123000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
8.90
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.77
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
120000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.95
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.01
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.53
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.51
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1959000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.84
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
751000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
344000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
296000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-926000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.90
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1368000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
856000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5596000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5830000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.93
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.13
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
434000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1959000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.84
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.57
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.52
CY2015Q4 us-gaap Share Price
SharePrice
4.29
CY2015Q1 us-gaap Share Price
SharePrice
16.72
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y22D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y135D
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
434000 USD
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y9M
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2342000 USD
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2009000 USD
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
19443000 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
208000 shares
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
938000 USD
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 USD
CY2016 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
-13529 shares
CY2017 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
-8669 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
265589000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
294301000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
489048000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
314155000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
267443000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295659000 USD
CY2016Q3 us-gaap Timesharing Transactions Stated Interest Rate For Notes Receivable
TimesharingTransactionsStatedInterestRateForNotesReceivable
0.06
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1729408 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1729408 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34640000 USD
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34640000 USD
CY2015 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2016 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2017 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
33000 USD
CY2015 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
261000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
808000 USD
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
196893 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49505817 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49925550 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50015869 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50618757 shares
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50237784 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50075847 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50333056 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50499948 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50599974 shares
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50590460 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50692012 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49925550 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50015869 shares
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50124302 shares
CY2016Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50237784 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50333056 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50499948 shares
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50554234 shares
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50590460 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49505817 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50075847 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50495119 shares
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risks.&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable.&#160;Acacia places its cash equivalents and short-term investments primarily in highly rated money market funds and investment grade marketable securities.&#160;Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">54%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">26%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">23%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">24%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">. One licensee individually represented </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Four licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.&#160;</font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">79%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">49%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company&#8217;s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.</font></div></div>
CY2017 us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Principles and Fiscal Year End.&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). </font></div></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the loan and equity instruments discussed at Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0000934549-18-000007-index-headers.html Edgar Link pending
0000934549-18-000007-index.html Edgar Link pending
0000934549-18-000007.txt Edgar Link pending
0000934549-18-000007-xbrl.zip Edgar Link pending
acaciaresearchcorp05.jpg Edgar Link pending
actg-20171231.xml Edgar Link completed
actg-20171231.xsd Edgar Link pending
actg-20171231_cal.xml Edgar Link unprocessable
actg-20171231_def.xml Edgar Link unprocessable
actg-20171231_lab.xml Edgar Link unprocessable
actg-20171231_pre.xml Edgar Link unprocessable
actg2017123110-k.htm Edgar Link pending
actgex211123117.htm Edgar Link pending
actgex231123117.htm Edgar Link pending
actgex311123117.htm Edgar Link pending
actgex312123117.htm Edgar Link pending
actgex321123117.htm Edgar Link pending
actgex322123117.htm Edgar Link pending
businessmodeloptionsv4a05.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stockperfgrapha01.jpg Edgar Link pending